Efficacy of Multi-Type Photolithography Flat Microstructure Lenses for Childhood Myopia Control

ConditionMyopia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-8
SponsorShanghai Eye Disease Prevention and Treatment Center

About this trial

The goal of this clinical trial is to learn if photolithographic flat microstructure lenses work to prevent myopia in children. It will also learn about the safety of different designs of photolithographic flat microstructure lenses. The main questions it aims to answer are:

Are photolithography flat microstructure lenses effective and safe in preventing myopia in children? Does the depth of tinted lenses affect visual quality? Researchers will compare photolithography flat microstructure lenses to a spectacle lenses with aspherical lenslets to see if photolithography flat microstructure lenses works to prevent myopia in children.

Participants will:

Wear photolithography flat microstructure lenses or Spectacle Lenses with Aspherical Lenslets more than 8H per day for 1 year.

Visit the clinic once every 3 months for checkups and tests.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age: 6 years ≤ age ≤ 8 years (calculated based on the informed consent date);

The spherical equivalent (SE) of both eyes is 0D to +1.00D (inclusive of boundary values) after cycloplegia;

Astigmatism: Cylindrical power of both eyes ≤ 1.00D;

Anisometropia: Difference in spherical equivalent between both eyes ≤ 1.00D;

Disqualifiers

History or presence of glaucoma, corneal disease, or other ocular organic disease, or acute or chronic ocular inflammation;

Combined with systemic major diseases, mental diseases, or systemic collagen metabolism diseases;

Used any myopia intervention drugs or devices in the past 3 months;

Those who have participated in other similar clinical studies in the past 3 months;

Trial design

Design model

Parallel

Treatments tested in this trial

  • wearing photolithography plano microstructure lenses with multi-point defocus design, non-fading optical property

    Device

    wearing photolithography plano microstructure lenses (PPML) with a multi-point defocus design, manufactured by Nuo Tong, which feature a non-fading optical property for more than 8 hours a day.

  • wearing Plano microstructure lenses featuring multi-point defocus design with aspherical lenslets (Essilor Stellest)

    Device

    wearing plano microstructure lenses featuring multi-point defocus design with aspherical lenslets (Essilor Stellest) for more than 8 hours.

  • wearing Photolithography Plano Microstructure Lenses incorporates a multi-point defocus optical architecture , featuring photochromic properties with a light transmittance of 55% post-activation

    Device

    Wearing Photolithography Plano Microstructure Lenses incorporates a multi-point defocus optical architecture manufactured by Nuo Tong, featuring photochromic properties with a light transmittance of 55% post-activation for more than 8 hours.

  • wearing Photolithography Plano Microstructure Lenses incorporates a multi-point defocus optical architecture , featuring photochromic properties with a light transmittance of 35% post-activation

    Device

    Wearing Photolithography Plano Microstructure Lenses incorporates a multi-point defocus optical architecture manufactured by Nuo Tong, featuring photochromic properties with a light transmittance of 35% post-activation for more than 8 hours.

  • wearing Photolithography Plano Microstructure Lenses designed to reduce contrast sensitivity and featuring a non-fading optical property

    Device

    wearing Photolithography Plano Microstructure Lenses designed by Nuo Tong to reduce contrast sensitivity and featuring a non-fading optical property for more than 8 hours

Treatment groups

255 Participants
are divided into 5 treatment groups
Group A: PPML(multi-point defocus design, non-fading, Nuo Tong)Experimental treatment 1 intervention
Group B: PPML (multi-point defocus design, color, light transmittance 55% after photochromism, Nuo Tong)Experimental treatment 1 intervention
Group C: PPML (multi-point defocus design, color, light transmittance 35% after photochromism, Nuo Tong)Experimental treatment 1 intervention
Group D: PPML (designed to reduce contrast, non-fading, Nuo Tong)Experimental treatment 1 intervention
Group E: Plano microstructure lenses (multi-point defocus design,Aspherical Lenslets, Essilor Stellest)Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

Use 1% cyclopentolate hydrochloride eye drops (Cyclogyl) for cycloplegia and compare the difference in Sphere equivalent refractive changes over 12 months.

Computerized refractometer testing, The formula for calculating sphere equivalent power: sphere power + 0.5 \* cylinder power

Time frame
From enrollment to the end of treatment at 12 month

Secondary outcomes

1

Difference in 12-month axial length (AL, mm) from baseline

Measure the length of the eye axis using the IOL Master 700 and compare the difference in eye axis length over 12 months.

Time frame
From enrollment to the end of treatment at 12 month

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: